DULAC EDWARD J III (EVP, Chief Financial Officer) received a stock award from INTELLIA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2026ACC: 0001193125-26-088254
Officer· EVP, Chief Financial Officer
Since Mar 2026
+148.82K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
148.82K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+61.28K
Price / share
—
Trade value
—
% of position
61.5%
3/1/2026
99.68K→160.96K
Total
Net shares
+61.28K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | A · Award | +61.28K | — | — | 61.5% | 99.68K | 160.96K |
| Total | +61.28K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
87.54K shares
Shares
+87.54K
Strike price
13.78
Held after
87.54K
Exercisable
—
3/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock87.54K shares | 3/1/2026 | A · Award | +87.54K | 13.78 | — | 87.54K |